Keep an eye on all of your favourite ASX-listed pot stocks, and compare Australia's cannabis companies against the HMMJ, the AORD, or the S&P 500 to see how the industry is doing.
Despite the ongoing COVID-19 pandemic and the seemingly endless "capital crunch" that faces cannabis companies, there is great potential in the Australian cannabis market, with Prohibition Partners predicting the Oceania region will be worth $1.55B by 2024, and 79% of that being comprised within Australia. While we are in a rough patch at the moment, there are real gains to be made in the years ahead.
In a conversation with Stockhead, The Green Fund's CEO, Mark Bernberg, stated that: "(Australia) is still the fastest growing prescription market globally, with significant increases in both patient numbers and prescribing doctors, So even with the regulatory limitations and red tape, we're getting to a position where that growth is opening up treatment options for additional conditions such as anxiety."
As Australia's cannabis landscape continues to grow and evolve, we thought it would be prudent for investors to have a one-stop-shop to analyze all of their favourite ASX pot stocks. This led us to create our Australian Cannabis Index!
Keen investors, or those looking to invest in the ASX cannabis landscape, can use our Australian Cannabis Stock index to compare current price levels with past prices to calculate market performance. The index is weighted using the prices of selected stocks, meaning that each company's stock is weighted by its price per share, and the index is an average of the share prices of all the companies.
Whether your focus is biotech's, ancillary companies, cultivators or medicinal marijuana stocks, you can find it all, at our Australian Cannabis Index.
Check it out here!
& Keep Up to Date
Get the latest pot stock recommendations, cannabis news
and industry updates straight to your inbox!